These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Case 9: initiation of urate-lowering therapy for advanced gout complicated by chronic renal insufficiency. Edwards NL Am J Med; 2006 Nov; 119(11 Suppl 1):S29-31. PubMed ID: 17059911 [No Abstract] [Full Text] [Related]
5. Optimising outcome on thiopurines in inflammatory bowel disease by co-prescription of allopurinol. Smith MA; Blaker P; Marinaki AM; Anderson SH; Irving PM; Sanderson JD J Crohns Colitis; 2012 Oct; 6(9):905-12. PubMed ID: 22386736 [TBL] [Abstract][Full Text] [Related]
6. [Biological drugs in inflammatory bowel disease. Valuable supplement--but only when conventional therapy is not sufficient]. Hellström PM; Schmidt D; Karlén P Lakartidningen; 2007 Oct 10-16; 104(41):2973-6. PubMed ID: 17977308 [No Abstract] [Full Text] [Related]
7. The drug therapy of ulcerative colitis and of Crohn's disease. Tumen HJ Semin Drug Treat; 1974; 3(4):339-49. PubMed ID: 4150770 [No Abstract] [Full Text] [Related]
8. Tolerability and safety of mercaptopurine in azathioprine-intolerant patients with inflammatory bowel disease. Lees CW; Maan AK; Hansoti B; Satsangi J; Arnott ID Aliment Pharmacol Ther; 2008 Feb; 27(3):220-7. PubMed ID: 17988235 [TBL] [Abstract][Full Text] [Related]
9. Therapy of inflammatory bowel disease, including use of immunosuppressive agents. Korelitz BI Clin Gastroenterol; 1980 May; 9(2):331-49. PubMed ID: 6104550 [No Abstract] [Full Text] [Related]
10. Inflammatory bowel disease and immune thrombocytopenic purpura: is there a correlation? Zlatanic J; Korelitz BI; Wisch N; Kim P; Ammirati M; Schwarz S; Gruenstein S; Lipsey L Am J Gastroenterol; 1997 Dec; 92(12):2285-8. PubMed ID: 9399771 [TBL] [Abstract][Full Text] [Related]
11. Management of steroid-dependent ulcerative colitis: immunomodulatory agents, biologics, or surgery? Velayos F; Mahadevan U Clin Gastroenterol Hepatol; 2007 Jun; 5(6):668-71. PubMed ID: 17544992 [No Abstract] [Full Text] [Related]
12. [When can TNF-alpha inhibitors against inflammatory bowel disease be withdrawn?]. Moum B Tidsskr Nor Laegeforen; 2007 Jun; 127(12):1673. PubMed ID: 17571118 [No Abstract] [Full Text] [Related]
13. Azathioprine pancreatitis in inflammatory bowel disease and successful subsequent treatment with mercaptopurine. Alexander S; Dowling D Intern Med J; 2005 Sep; 35(9):570-1. PubMed ID: 16105163 [No Abstract] [Full Text] [Related]
14. [Azathioprine, 6-mercaptopurine, and inflammatory diseases of the intestine]. Beaugerie L; Gendre JP Gastroenterol Clin Biol; 1990; 14(3):230-40. PubMed ID: 2188863 [No Abstract] [Full Text] [Related]
15. Efficacy and safety of azathioprine and 6-mercaptopurine in Japanese pediatric patients with ulcerative colitis: a survey of the Japanese Society for Pediatric Inflammatory Bowel Disease. Tajiri H; Tomomasa T; Yoden A; Konno M; Sasaki M; Maisawa S; Sumazaki R; Shimizu T; Toyoda S; Etani Y; Nakacho M; Ushijima K; Kobayashi A; Digestion; 2008; 77(3-4):150-4. PubMed ID: 18577852 [TBL] [Abstract][Full Text] [Related]
16. Cyclosporine-induced hyperuricemia and gout in renal transplants. Ben Hmida M; Hachicha J; Bahloul Z; Kaddour N; Kharrat M; Jarraya F; Jarraya A Transplant Proc; 1995 Oct; 27(5):2722-4. PubMed ID: 7482890 [No Abstract] [Full Text] [Related]
17. [Myelotoxicity due to interaction between azathioprine and allopurinol in a patient with Crohn's disease]. Millán M; Castro-Fernández M; Ampuero J; Romero-Gómez M Gastroenterol Hepatol; 2013 Apr; 36(4):298-9. PubMed ID: 23274032 [No Abstract] [Full Text] [Related]